Biosimilars Resource Center
Pharmacists are well positioned to help oversee the integration of biosimilars into patient care. Pharmacists have the opportunity to educate providers and patients about the biosimilar landscape and help implement an efficient workflow to support biosimilar adoption and use.
This resource center aims to assist pharmacists and other healthcare practitioners with meaningful information and resources that will allow them to better understand biosimilars, their economic impact, as well as how to better implement biosimilars in therapeutic areas within various practice settings.
Guidelines and Articles
Explore essential biosimilar guidelines and articles to support safe, effective, and informed clinical use.
American Journal of Health-System Pharmacy (AJHP)
- How to Select a Best-Value Biological Medicine? A Practical Model to Support Hospital Pharmacists [2022]
- Healthcare System Conversion to a Biosimilar: Trials and Tribulations [2021]
- Biosimilar Strategic Implementation at a Large Health System [2021]
- Forum discusses biosimilars, better biologicals [2011]
- Biosimilars: Policy, clinical, and regulatory considerations [2008]
- Implications of biosimilars for the future [2008]
- Biosimilars: Illustration of scientific issues in two examples [2008]
U.S. Food and Drug Administration (FDA)
- Biosimilar Resources
- Scientific Considerations in Demonstrating Biosimilarity to a Reference Product
- Quality Considerations in Demonstrating Biosimilarity to a Reference Protein Product
- Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009
Other
- Rationale, Opportunities, and Reality of Biosimilar Medications – NEJM
- New and Upcoming Biosimilar Launches – CardinalHealth
- The State of the Art in the Development of Biosimilars – ASCPT
- NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives – J Natl Compr Canc Netw
- Biosimilar Medicines Uptake: The Role of the Clinical Pharmacist – Explor Res Clin Soc Pharm
- Real-World Evidence of a Successful Biosimilar Adoption Program
ADVERTISEMENT
Podcasts
- Engaging the Experts - A New Landscape: Biosimilars in Multiple Sclerosis [2023]
- A New Landscape: Biosimilars in Autoimmune Indications [2023]
- Accelerating Biosimilar Adoption: Conversation With the Experts [2022]
- Best Practices in Formulary Management Unique Strategies for Biosimilar Adoption [2020]
Financial Considerations
- The Cost Savings of Biosimilars Can Help Increase Patient Access and Lift the Financial Burden of Health Care Systems
- Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees
- Biosimilars: Considerations for Payers
- Overcoming Barriers to Biosimilar Adoption: Real-World Perspectives from a National Payer and Provider Initiative
